Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
153M
-
Shares change
-
+8.84M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$68.7M
-
Put/Call ratio
-
1.08
-
Number of buys
-
108
-
Number of sells
-
-84
-
Price
-
$7.43
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q1 2025
245 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q1 2025.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 153M shares
.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), Rubric Capital Management LP (13.1M shares), BlackRock, Inc. (12.2M shares), VANGUARD GROUP INC (11.1M shares), ARK Investment Management LLC (7.73M shares), AMERIPRISE FINANCIAL INC (6.64M shares), Nikko Asset Management Americas, Inc. (6.09M shares), Sumitomo Mitsui Trust Group, Inc. (6.09M shares), BRAIDWELL LP (4.8M shares), and MILLENNIUM MANAGEMENT LLC (3M shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.